Back

Sex differences in early study discontinuation and study drug withdrawal: insights from REDUCE-IT

28 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Coronary artery disease in women: risk, care gaps, and real-world outcomes Cardiovascular Disease in Women ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Marte Van Der Bijl

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Autonomic phenotype and antecedent autonomic symptoms in spontaneous coronary artery dissection
Doctor M. Seeley (Adelaide, AU)
Abstract Slides
Presentation thumbnail
Cardiovascular-renal-metabolic syndrome and mortality in non-obstructive coronary artery disease: prognostic impact of diabetes in women.
Mr D. Martins (BR)
Abstract Slides
Presentation thumbnail
CCTA-guided management of NSTE-ACS in women: a tailored diagnostic strategy
Doctor I. Chapman (Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
Sex-specific outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in women with coronary artery disease: a systematic review and meta-analysis
Mr P. Batista (BR)
Abstract Slides
Presentation thumbnail
Sex-difference in cardiovascular outcomes following achieved LDL-C Levels <1.0 mmol/L in patients with coronary artery disease
Doctor F. Matsuyama (Osaka, JP)
Abstract Slides

Access the full session

Session thumbnail
Coronary artery disease in women: risk, care gaps, and real-world outcomes

The Event

Event poster

ESC Congress 2026

28 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Sex-related differences regarding results of lipid-lowering therapies, implemented through telematic consultation, after an acute coronary syndrome.
13 April 2023
thumbnail
Congress Presentation
Representativeness of women and racial/ethnic minorities in randomized clinical trials on bempedoic acid
7 April 2022
thumbnail
Congress Presentation
Do we need trials to account for sex differences in HFpEF?
24 May 2022
thumbnail
Congress Presentation
REDUCE-IT: outcomes by baseline statin type
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources